PULMONX CORPORATION (LUNG) Capital expenditures 2018–2025
PULMONX CORPORATION (LUNG) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$452,000FY2025 · since FY2018: $316,000 → $452,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $452,000 | -68.8% |
| FY2024 | $1.4M | +79.3% |
| FY2023 | $807,000 | -38.8% |
| FY2022 | $1.3M | -64.1% |
| FY2021 | $3.7M | +303.0% |
| FY2020 | $911,000 | +26.5% |
| FY2019 | $720,000 | +127.8% |
| FY2018 | $316,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice